Article
India-based Hetero's Paxlovid generic gets WHO backing
Rating:
0.0
Views:
64
Likes:
1
Library:
1
India's Hetero said on Tuesday that its generic version of Paxlovid, an antiviral treatment for COVID-19 developed by Pfizer Inc , was added to the World Health Organization's prequalification list, which serves as a benchmark for procurement of medicines by developing countries.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value